Jaejin An

1.3k total citations · 1 hit paper
72 papers, 820 citations indexed

About

Jaejin An is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Economics and Econometrics. According to data from OpenAlex, Jaejin An has authored 72 papers receiving a total of 820 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Cardiology and Cardiovascular Medicine, 18 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Economics and Econometrics. Recurrent topics in Jaejin An's work include Blood Pressure and Hypertension Studies (22 papers), Atrial Fibrillation Management and Outcomes (13 papers) and Health Systems, Economic Evaluations, Quality of Life (10 papers). Jaejin An is often cited by papers focused on Blood Pressure and Hypertension Studies (22 papers), Atrial Fibrillation Management and Outcomes (13 papers) and Health Systems, Economic Evaluations, Quality of Life (10 papers). Jaejin An collaborates with scholars based in United States, Philippines and Canada. Jaejin An's co-authors include Kristi Reynolds, Fang Niu, T. Craig Cheetham, Michael B. Nichol, Rong Wei, Steven J. Jacobsen, Stephen Sidney, Charles P. Quesenberry, Teresa N. Harrison and Yiyi Zhang and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Jaejin An

60 papers receiving 799 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10‐Year Atherosclerotic Cardiovascular Risk Prediction

2025 16 citations Hui Zhou, Yiyi Zhang et al. Journal of the American Heart Association profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jaejin An United States	17	261	245	115	85	74	72	820
Fang Niu United States	14	91 0.3×	147 0.6×	61 0.5×	103 1.2×	67 0.9×	49	777
Iacopo Cricelli Italy	17	96 0.4×	110 0.4×	138 1.2×	134 1.6×	39 0.5×	43	833
Praveen K. Potukuchi United States	19	141 0.5×	130 0.5×	65 0.6×	52 0.6×	134 1.8×	53	1.1k
Jian Ying United States	18	115 0.4×	195 0.8×	120 1.0×	108 1.3×	125 1.7×	55	1.1k
Christiano Argano Italy	19	466 1.8×	257 1.0×	357 3.1×	38 0.4×	130 1.8×	62	1.3k
Chandrasekar Gopalakrishnan United States	13	114 0.4×	95 0.4×	72 0.6×	31 0.4×	41 0.6×	28	553
José Salvador García Morillo Spain	14	115 0.4×	81 0.3×	162 1.4×	40 0.5×	53 0.7×	56	632
Ann M. Sheehy United States	17	261 1.0×	221 0.9×	80 0.7×	21 0.2×	97 1.3×	44	934
Olive Tang United States	19	249 1.0×	180 0.7×	130 1.1×	91 1.1×	67 0.9×	65	920
Sheryl L. Chow United States	16	758 2.9×	179 0.7×	122 1.1×	60 0.7×	134 1.8×	43	1.3k

Countries citing papers authored by Jaejin An

Since Specialization

Citations

This map shows the geographic impact of Jaejin An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaejin An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaejin An more than expected).

Fields of papers citing papers by Jaejin An

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaejin An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaejin An. The network helps show where Jaejin An may publish in the future.

Co-authorship network of co-authors of Jaejin An

This figure shows the co-authorship network connecting the top 25 collaborators of Jaejin An. A scholar is included among the top collaborators of Jaejin An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaejin An. Jaejin An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mazzotti, Diego R., Jaejin An, Brendan T Keenan, et al.. (2025). Positive airway pressure therapy and cardiovascular events in obstructive sleep apnoea: an observational clinical cohort study. Sleep Medicine. 139. 108732–108732.

An, Jaejin, Heidi Fischer, Liang Ni, et al.. (2025). Development and Validation of an Incident Hypertension Risk Prediction Model for Young Adults. Journal of the American Heart Association. 14(14). e040769–e040769.

Zhou, Hui, Yiyi Zhang, Soon Kyu Choi, et al.. (2025). Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10‐Year Atherosclerotic Cardiovascular Risk Prediction. Journal of the American Heart Association. 14(4). e039454–e039454. 16 indexed citations breakdown →

Mefford, Matthew T., Hui Zhou, Lori D. Bash, et al.. (2025). Lipid-lowering Therapy Utilization, Adherence, and Outcomes Among Adults With and at-Risk for Atherosclerotic Cardiovascular Disease in an Integrated Healthcare Delivery System in Southern California. The American Journal of Cardiology. 255. 55–63.

An, Jaejin, Teresa N. Harrison, Liang Ni, et al.. (2025). Factors Associated with Treatment Intensification for Uncontrolled Hypertension in a US Health System. Journal of General Internal Medicine. 1 indexed citations

An, Jaejin, John J. Sim, Hui Zhou, et al.. (2024). Blood Pressure Reduction and Changes in Antihypertensive Medication Use Among Patients With Hypertension Who Initiated Sodium‐Glucose Cotransporter‐2 Inhibitors. Journal of Clinical Hypertension. 26(11). 1318–1321. 3 indexed citations

Xu, Yizhe, Catherine G. Derington, Joshua A. Jacobs, et al.. (2024). Trends in Initial Antihypertensive Medication Prescribing Among >2.8 Million Veterans Newly Diagnosed With Hypertension, 2000 to 2019. Journal of the American Heart Association. 13(20). e036557–e036557. 3 indexed citations

An, Jaejin, Heidi Fischer, Liang Ni, et al.. (2024). Association Between Young Adult Characteristics and Blood Pressure Trajectories. Journal of the American Heart Association. 13(8). e033053–e033053. 3 indexed citations

An, Jaejin, et al.. (2024). Blood Pressure Trajectories During Young Adulthood and Cardiovascular Events in Later Life. American Journal of Hypertension. 38(1). 38–45.

10.

An, Jaejin. (2024). High-Speed Rail Network, Entrepreneurial Activity and High-Quality Development: Empirical Data from Chinese Cities. Theoretical Economics Letters. 14(6). 2382–2406. 1 indexed citations

11.

Harrison, Teresa N., Hui Zhou, Rong Wei, et al.. (2023). Blood Pressure Control Among Black and White Adults Following a Quality Improvement Program in a Large Integrated Health System. JAMA Network Open. 6(1). e2249930–e2249930. 11 indexed citations

12.

Choi, Soon Kyu, Kristi Reynolds, Hui Zhou, et al.. (2023). Validation of ICD‐10 hospital discharge diagnosis codes to identify incident and recurrent ischemic stroke from a US integrated healthcare system. Pharmacoepidemiology and Drug Safety. 32(12). 1439–1445. 11 indexed citations

13.

Derington, Catherine G., Glenn K. Goodrich, Stanley Xu, et al.. (2023). Association of Direct Oral Anticoagulation Management Strategies With Clinical Outcomes for Adults With Atrial Fibrillation. JAMA Network Open. 6(7). e2321971–e2321971. 4 indexed citations

14.

Zhang, Yiyi, Joseph E. Schwartz, Byron C. Jaeger, et al.. (2021). Association Between Ambulatory Blood Pressure and Coronary Artery Calcification: The JHS. Hypertension. 77(6). 1886–1894. 6 indexed citations

15.

An, Jaejin, Hui Zhou, Rong Wei, et al.. (2021). COVID-19 morbidity and mortality associated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers use among 14,129 patients with hypertension from a US integrated healthcare system. SHILAP Revista de lepidopterología. 9. 100088–100088. 3 indexed citations

16.

An, Jaejin, Catherine G. Derington, Tiffany Luong, et al.. (2020). Fixed-Dose Combination Medications for Treating Hypertension: A Review of Effectiveness, Safety, and Challenges. Current Hypertension Reports. 22(11). 95–95. 16 indexed citations

17.

Jackevicius, Cynthia A., Jaejin An, Dennis T. Ko, et al.. (2019). Submissions from the SPRINT Data Analysis Challenge on clinical risk prediction: a cross-sectional evaluation. BMJ Open. 9(3). e025936–e025936. 2 indexed citations

18.

An, Jaejin & Quang A. Le. (2016). The Economic Burden of Types of Comorbidity for Patients with Diabetes Mellitus. Value in Health. 19(3). A29–A29. 1 indexed citations

19.

Reynolds, Kristi, Jaejin An, Jun Wu, et al.. (2016). Treatment discontinuation of oral hypoglycemic agents and healthcare utilization among patients with diabetes. Journal of Diabetes and its Complications. 30(8). 1443–1451. 8 indexed citations

20.

An, Jaejin, Fang Niu, Nazia Rashid, et al.. (2014). TIME IN THERAPEUTIC RANGE ≥55% VERSUS <55% ON WARFARIN THERAPY OUTCOMES IN NON-VALVULAR ATRIAL FIBRILLATION PATIENTS. Journal of the American College of Cardiology. 63(12). A359–A359. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact